Benralizumab strongly reduces blood basophils in severe eosinophilic asthma.

Subjects

Subjects :

Asthma blood
Asthma diagnosis
Asthma immunology
Basophils immunology
Case-Control Studies
Eosinophilia blood
Eosinophilia diagnosis
Eosinophilia immunology
Female
Humans
Leukocyte Count
Male
Middle Aged
Severity of Illness Index
Time Factors
Treatment Outcome
Anti-Asthmatic Agents therapeutic use
Antibodies, Monoclonal, Humanized therapeutic use
Asthma drug therapy
Basophils drug effects
Eosinophilia drug therapy

Details

Language :

English

ISSN :

1365-2222

Volume :

50

Issue :

11

Database :

MEDLINE

Journal :

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Publication Type :

Report

Accession number :

32762056

Full Text :

https://doi.org/10.1111/cea.13720